These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18817634)

  • 1. Discovery and characterization of a novel inhibitor of CDC25B, LGH00045.
    Feng X; Wang LN; Zhou YY; Yu HP; Shen Q; Zang Y; Zhou YB; Li JY; Zhang HX; Li J
    Acta Pharmacol Sin; 2008 Oct; 29(10):1268-74. PubMed ID: 18817634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
    Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
    Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases.
    Viry E; Anwar A; Kirsch G; Jacob C; Diederich M; Bagrel D
    Int J Oncol; 2011 Apr; 38(4):1103-11. PubMed ID: 21253673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the CDC25 phosphatases.
    Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
    Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
    Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
    Lavecchia A; Di Giovanni C; Novellino E
    Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of macrocyclic inhibitors of phosphatase cdc25B.
    Bäurle S; Blume T; Günther J; Henschel D; Hillig RC; Husemann M; Mengel A; Parchmann C; Schmid E; Skuballa W
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1673-7. PubMed ID: 15026048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel synthetic inhibitor of CDC25 phosphatases: BN82002.
    Brezak MC; Quaranta M; Mondésert O; Galcera MO; Lavergne O; Alby F; Cazales M; Baldin V; Thurieau C; Harnett J; Lanco C; Kasprzyk PG; Prevost GP; Ducommun B
    Cancer Res; 2004 May; 64(9):3320-5. PubMed ID: 15126376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
    J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
    Valente S; Bana E; Viry E; Bagrel D; Kirsch G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
    Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
    Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.